As the first publicly traded company in the U.S. to receive DEA federal authorization for the growth, manufacturing, and sale of cannabis and related products for pharmaceutical applications, and research, Bright Green is the largest player in the industry.
Bright Green’s mission is to be the premier federally-authorized provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured in exact formulations for research and pharmaceutical applications and an active ingredient to consumer-based solutions. Through legal partnerships with state and federal agencies, the company can operate at scale in a manner unprecedented in this emerging market, addressing compliance, security, and integrity.
Terry Rafih
Executive Chairman
Bright Green’s mission is to be the premier federally-authorized provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured in exact formulations for research and pharmaceutical applications and an active ingredient to consumer-based solutions. Through legal partnerships with state and federal agencies, the company can operate at scale in a manner unprecedented in this emerging market, addressing compliance, security, and integrity.
Terry Rafih
Executive Chairman
Subscribe to learn about the latest medical cannabis research, keep current on new resources and stay up on other news related to plant-based therapies